Tumor suppressor maspin as a modulator of host immune response to cancer

Despite the promising clinical outcome, the primary challenge of the curative cancer immunotherapy is to overcome the dichotomy of the immune response: tumor-evoked immunostimulatory versus tumor-induced immunosuppressive. The goal needs to be two-fold, to re-establish sustainable antitumor-cancer...

Full description

Bibliographic Details
Main Authors: Sijana H. Dzinic, Maria M. Bernardo, Daniel S.M. Oliveira, Marian Wahba, Wael Sakr, Shijie Sheng
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2015-10-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
Online Access:https://bjbms.org/ojs/index.php/bjbms/article/view/783